HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating

2 days ago 3

Ashar Jawad

Thu, January 15, 2026 astatine 10:35 AM CST 2 min read

Alumis Inc. (NASDAQ:ALMS) is among the 14 champion booming stocks to bargain close now. On January 9, HC Wainwright & Co. lifted its terms people connected the banal to $40 from $20, portion maintaining a Buy standing connected the shares.

HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating

HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating

The accommodation came aft the institution shared promising results earlier successful the week from the Phase 3 ONWARD1 and ONWARD2 trials evaluating the efficacy of envudeucitinib successful patients with mean to terrible plaque psoriasis.

Both trials achieved their superior and secondary endpoints. Moreover, the results demonstrated harmless usage and tolerability among patients, who besides reported a important betterment successful their prime of beingness done eased itching. Alumis Inc. is readying to record for the drug’s support with the FDA during the second fractional of 2026.

HC Wainwright & Co. believes the results person ‘reset expectations’ successful the country of oral tyrosine kinase 2 (TYK2). The steadfast sees a beardown accidental of the FDA approving envudeucitinib, which could pb to a large gross surge for the company.

Several different probe firms, including Wells Fargo and Morgan Stanley, besides revised their positions connected the banal pursuing the announcement of proceedings results by expanding their terms targets connected Alumis Inc. (NASDAQ:ALMS).

As of the adjacent of concern connected January 12, Wall Street analysts person a statement Strong Buy standing connected the banal with a one-year mean stock terms people of $37.67, representing an upside of 78.62%.

Alumis Inc. (NASDAQ:ALMS) is simply a biopharmaceutical institution with expertise successful processing targeted therapies to dainty immune-mediated diseases.

While we admit the imaginable of ALMS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best S&P 500 Stocks to Buy Now and 11 Most Oversold S&P 500 Stocks Heading into 2026

Disclosure: None.


Read Entire Article